Infectious Disease and Microbiology – Ewingella americana

Overview

Ewingella americana is a rare aerobic Gram-negative bacillus historically classified within the Enterobacteriaceae. It is infrequently recovered from clinical specimens, and because of its rarity, its overall clinical significance and pathogenic potential remain incompletely defined.

Reported infections have occurred particularly in immunocompromised patients and include bacteremia, wound infections, and occasional respiratory tract infections.

Microbiologic Characteristics

Ewingella americana is:

• An aerobic Gram-negative bacillus

• Historically classified within the Enterobacteriaceae group

• A rare opportunistic human pathogen

Its uncommon isolation makes it difficult to establish its precise role in many clinical settings.

Epidemiology

E. americana is rarely recovered in clinical cultures.

Consequently, considerably less is known about its epidemiology than about more common Gram-negative pathogens.

Clinical Significance

The clinical significance of E. americana can sometimes be uncertain, particularly when it is recovered from specimens that may contain colonizing organisms.

However, documented invasive infections indicate that it can function as an opportunistic pathogen, especially in susceptible hosts.

Risk Factors

Reported infections are particularly relevant in patients with:

• Immunocompromising conditions

• Significant underlying disease

• Wounds or disrupted tissue barriers

• Healthcare exposure

Because relatively few cases have been reported, the complete spectrum of risk factors remains uncertain.

Bacteremia

E. americana has been reported as a cause of bacteremia, particularly in immunocompromised patients.

Isolation from blood should therefore be evaluated carefully in conjunction with the patient’s clinical condition rather than automatically dismissed because the organism is uncommon.

Wound Infection

The organism has also been associated with wound infections, particularly in patients with impaired host defenses.

Clinical significance is more convincing when the organism is recovered from an infected wound together with compatible inflammatory findings.

Respiratory Tract Infection

E. americana has rarely been associated with respiratory tract infection.

Because respiratory specimens can contain colonizing organisms, recovery from the respiratory tract should be interpreted together with clinical and radiologic evidence of infection.

Diagnosis

Diagnosis is established by:

Culture of the organism

Because E. americana is unusual, accurate laboratory identification is important.

For clinically significant isolates, antimicrobial susceptibility testing is particularly valuable because predictable susceptibility patterns cannot always be assumed.

Treatment

There are limited clinical data regarding optimal antimicrobial therapy for E. americana infection.

The source reports activity with agents including:

• Cefotaxime

• Piperacillin–tazobactam

• Trimethoprim–sulfamethoxazole

However, antimicrobial susceptibility should ideally be determined for the individual isolate.

Multidrug Resistance

An important concern is that multidrug-resistant isolates have been reported.

Therefore:

Rare organism + uncertain susceptibility + possible multidrug resistance

→ Culture and susceptibility-guided therapy are particularly important

Combination Therapy

The source describes clinical use of combinations involving:

Trimethoprim–sulfamethoxazole

or

Cefotaxime

or

An antipseudomonal penicillin

combined with an:

Aminoglycoside

Because evidence is limited, these historical treatment approaches should not be considered universally appropriate for every isolate.

Treatment Principle

The most important therapeutic concept is:

Identify the organism

• ●

Perform antimicrobial susceptibility testing

• ●

Choose therapy according to susceptibility and infection severity

This is especially important because E. americana is uncommon and antimicrobial resistance has been reported.

High-Yield Clinical Pattern

Immunocompromised patient

• ●

Bacteremia or wound infection

• ●

Unusual aerobic Gram-negative bacillus

• ●

Potential multidrug resistance

→ Consider Ewingella americana

Exam Essentials

Organism: Ewingella americana

Type: Gram-negative bacillus

Oxygen requirement: Aerobic

Traditional classification: Enterobacteriaceae

Frequency: Very rare

Clinical significance: Incompletely defined

Important host: Immunocompromised patient

Major reported infections: Bacteremia and wound infection

Respiratory infection: Rare

Diagnosis: Culture

Important laboratory step: Antimicrobial susceptibility testing

Resistance: Multidrug resistance has been reported

Reported active agents in source: Cefotaxime, piperacillin–tazobactam, trimethoprim–sulfamethoxazole

Treatment principle: Susceptibility-guided therapy

Key clinical pearl: Ewingella americana is a rare opportunistic Gram-negative bacillus associated mainly with bacteremia and wound infection in immunocompromised patients; because clinical experience is limited and multidrug resistance can occur, antimicrobial susceptibility testing is central to treatment selection.